Business Segments Macro Group Pharmaceuticals (Macro Capital) S.A.E
Stocks
MCRO
EGS7D971C011
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.490 EGP | -2.61% |
|
+2.05% | +30.70% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 02-19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
Beauty Care Products | ||||||
Manufacture and Sale of Cosmetics | 594M | 730M | 526M | 520M | 895M | |
Total Assets | 577M | 850M | 514M | 615M | 778M | |
Interest Expense | -8.15M | -13.48M | -29.48M | -46.6M | -34.43M | |
Income Tax Expense | 48.49M | 53.48M | 2.6M | -1.51M | 6.07M | |
CAPEX | -5.81M | -8.8M | -6.44M | -12.32M | -42.48M | |
EBT | 196M | 227M | -270M | -39.56M | 122M | |
Gross Profit | 474M | 562M | 296M | 323M | 609M | |
D&A | 6.6M | 13.62M | 16.72M | 16.56M | 17.13M | |
Operating Income | 204M | 234M | -207M | 15.32M | 135M | |
Net Income | 148M | 174M | -273M | -38.1M | 116M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
Egypt | - | 699M | 511M | 485M | 864M | |
Export | - | 30.46M | 15.02M | 34.67M | 30.8M |
Select your edition
All financial news and data tailored to specific country editions
